Elevance Health Net premiums earned increased by 0.8% to $41.02B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $40.89B to $41.02B. Over 4 years (FY 2021 to FY 2025), Net premiums earned shows an upward trend with a 8.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in the insurance book of business, while a decrease may signal shrinking market share or increased reinsurance activity.
This represents the portion of insurance premiums that the company has recognized as revenue during the reporting period...
Standard across all insurance carriers; peers typically report this as the primary top-line revenue driver.
net_premiums_earned| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.53B | $30.40B | $30.77B | $32.79B | $33.08B | $33.72B | $33.65B | $35.87B | $36.59B | $35.26B | $35.14B | $35.70B | $35.42B | $36.81B | $36.25B | $40.89B | $41.27B | $41.79B | $40.69B | $41.02B |
| QoQ Change | — | +6.5% | +1.2% | +6.6% | +0.9% | +2.0% | -0.2% | +6.6% | +2.0% | -3.6% | -0.3% | +1.6% | -0.8% | +3.9% | -1.5% | +12.8% | +0.9% | +1.3% | -2.6% | +0.8% |
| YoY Change | — | — | — | — | +15.9% | +10.9% | +9.4% | +9.4% | +10.6% | +4.6% | +4.4% | -0.5% | -3.2% | +4.4% | +3.2% | +14.5% | +16.5% | +13.5% | +12.3% | +0.3% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Health Benefits Segment | $35.10B | $36.45B | $35.74B | $39.59B | $39.71B | $40.30B | $39.86B | $40.45B |
| Carelon Services Segment | $794.00M | $680.00M | $748.00M | $1.50B | $1.86B | $1.76B | $1.19B | $779.00M |
| Carelon Total | $794.00M | $680.00M | — | — | — | — | — | — |
| CarelonRx Segment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Corporate & Other | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $35.42B | $36.81B | $36.25B | $40.89B | $41.27B | $41.79B | $40.69B | $41.02B |
Carelon Total, Corporate & Other Segment, Segment Eliminations were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.